PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33737010-11	2021	In addition, ATP and BzATP increased the expression of p-Akt, p-GSK-3beta and beta-catenin via P2X7R.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	21-26	AKT serine/threonine kinase 1	Homo sapiens	57-60	
28412208-9	2017	Treatment with P2X7R agonist BzATP led to the activation of Akt and NF-kappaB pathways.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	29-34	AKT serine/threonine kinase 1	Homo sapiens	60-63	
28412208-10	2017	Consequently, we revealed that BzATP accelerated the proliferation of CRC cells, whereas co-incubation with PI3K/Akt inhibitor LY294002 significantly impaired BzATP-induced proliferation of CRC cells.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	159-164	AKT serine/threonine kinase 1	Homo sapiens	113-116	
33737010-12	2021	P13/Akt pathway inhibitor LY294002 inhibited the proliferation of CRC cells, and the P13/Akt signaling was required for BzATP induced the proliferation of CRC cells.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	120-125	AKT serine/threonine kinase 1	Homo sapiens	4-7	
33737010-12	2021	P13/Akt pathway inhibitor LY294002 inhibited the proliferation of CRC cells, and the P13/Akt signaling was required for BzATP induced the proliferation of CRC cells.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	120-125	AKT serine/threonine kinase 1	Homo sapiens	89-92